dynalabs.us - Client Case StudyWorking Towards 503B Certification
Working Towards 503B Certification - DYNALABS









Search Preview

Working Towards 503B Certification - DYNALABS

dynalabs.us
888.396.2522 314.241.3962
.us > dynalabs.us

SEO audit: Content analysis

Language Error! No language localisation is found.
Title Working Towards 503B Certification - DYNALABS
Text / HTML ratio 9 %
Frame Excellent! The website does not use iFrame solutions.
Flash Excellent! The website does not have any flash contents.
Keywords cloud DYNALABS Facility testing facility Services Tech Bulletin companies Program Validation Drug • DVx™ service Process Customer FDA Registration company System
Keywords consistency
Keyword Content Title Description Headings
DYNALABS 32
Facility 14
testing 14
facility 8
Services 8
Tech 7
Headings
H1 H2 H3 H4 H5 H6
1 1 4 0 0 0
Images We found 16 images on this web page.

SEO Keywords (Single)

Keyword Occurrence Density
DYNALABS 32 1.60 %
Facility 14 0.70 %
testing 14 0.70 %
facility 8 0.40 %
Services 8 0.40 %
Tech 7 0.35 %
Bulletin 7 0.35 %
companies 6 0.30 %
Program 6 0.30 %
Validation 6 0.30 %
Drug 6 0.30 %
• 5 0.25 %
DVx™ 4 0.20 %
service 4 0.20 %
Process 4 0.20 %
Customer 4 0.20 %
FDA 4 0.20 %
Registration 4 0.20 %
company 4 0.20 %
System 3 0.15 %

SEO Keywords (Two Word)

Keyword Occurrence Density
Facility A 12 0.60 %
2018 Tech 7 0.35 %
Tech Bulletin 7 0.35 %
testing companies 5 0.25 %
Validation Program 4 0.20 %
testing company 4 0.20 %
to build 3 0.15 %
Towards 503B 3 0.15 %
Working Towards 3 0.15 %
companies The 3 0.15 %
for a 3 0.15 %
503B Certification 3 0.15 %
other testing 3 0.15 %
A began 3 0.15 %
they needed 3 0.15 %
with other 3 0.15 %
DYNALABS LLC 3 0.15 %
testing facility 3 0.15 %
a 503A 2 0.10 %
outsourcing facility 2 0.10 %

SEO Keywords (Three Word)

Keyword Occurrence Density Possible Spam
2018 Tech Bulletin 7 0.35 % No
with other testing 3 0.15 % No
Working Towards 503B 3 0.15 % No
Towards 503B Certification 3 0.15 % No
Facility A began 3 0.15 % No
other testing companies 3 0.15 % No
testing companies The 3 0.15 % No
looking for a 2 0.10 % No
experiences with other 2 0.10 % No
Facility A approached 2 0.10 % No
a testing company 2 0.10 % No
began looking for 2 0.10 % No
DYNALABS investment doubles 2 0.10 % No
investment doubles the 2 0.10 % No
503b outsourcing facility 2 0.10 % No
doubles the size 2 0.10 % No
the size of 2 0.10 % No
size of its 2 0.10 % No
of its testing 2 0.10 % No
its testing facility 2 0.10 % No

SEO Keywords (Four Word)

Keyword Occurrence Density Possible Spam
with other testing companies 3 0.15 % No
Working Towards 503B Certification 3 0.15 % No
experiences with other testing 2 0.10 % No
doubles the size of 2 0.10 % No
other testing companies The 2 0.10 % No
A began looking for 2 0.10 % No
DYNALABS investment doubles the 2 0.10 % No
investment doubles the size 2 0.10 % No
began looking for a 2 0.10 % No
the size of its 2 0.10 % No
size of its testing 2 0.10 % No
of its testing facility 2 0.10 % No
Facility A began looking 2 0.10 % No
a 503b outsourcing facility 2 0.10 % No
User Registration Account Registration 2 0.10 % No
some cGMP Good Manufacturing 1 0.05 % No
a testing company to 1 0.05 % No
of a testing company 1 0.05 % No
Facility A approached some 1 0.05 % No
A approached some cGMP 1 0.05 % No

Internal links in - dynalabs.us

Products & Services
Products & Services - DYNALABS
Lab Services State-of-the-art analytical testing laboratory provides data you need to run your business.
Lab Services - DYNALABS
On Site Testing Less than 4 seconds to objectively verify drug identity and strength in your facility.
DVx™ On site Drug Verification - DYNALABS
CQI Program Use our expert knowledge of the pharmaceutical industry to help you grow your business.
Continuous Quality Improvement (CQI) - DYNALABS
Consulting Services
Consulting Services - DYNALABS
Customer Improvement System
Customer Improvement System - DYNALABS
Customer Production System
Customer Production System - DYNALABS
Data Analytics
Data Analytics - DYNALABS
Laboratory Services
Laboratory Services - DYNALABS
Test Services
Test Services - DYNALABS
API (Active Pharmaceutical Ingredient ) list
API (Active Pharmaceutical Ingredient ) list - DYNALABS
DVx™ Specifications
DVx™ Specifications - DYNALABS
DVx™ Validation Process
DVx™ Validation Process - DYNALABS
DVx™ General FAQs
DVx™ General FAQs - DYNALABS
On-site Managed Services
On-site Managed Services - DYNALABS
Consulting
Consulting - DYNALABS
Improvement Systems
Improvement Systems - DYNALABS
Production System
Production System - DYNALABS
Six Step Approach
Six Step Approach - DYNALABS
DYNALABS OOS Process
DYNALABS OOS Process - DYNALABS
Online Services
Online Services - DYNALABS
Sample Submission
Sample Submission - DYNALABS
Customer Service
Customer Service - DYNALABS
What We Do
What We Do - DYNALABS
Hospital Pharmacies
Hospital Pharmacies - DYNALABS
Stability of Drug
Stability of Drug - DYNALABS
Diversion of Drug
Diversion of Drug - DYNALABS
In House Training
In House Training - DYNALABS
Product Validation
Product Validation - DYNALABS
Drug Investigation
Drug Investigation - DYNALABS
Compounding Pharmacies
Compounding Pharmacies - DYNALABS
People: Training Validation Program
People: Training Validation Program - DYNALABS
Materials: Vendor Qualification Program
Materials: Vendor Qualification Program - DYNALABS
Equipment: Performance Validation Program
Equipment: Performance Validation Program - DYNALABS
Process: Process Validation Program
Process: Process Validation Program - DYNALABS
Product: Product Validation Program
Product: Product Validation Program - DYNALABS
Frequently Asked Questions
Frequently Asked Questions - DYNALABS
Company
Company - DYNALABS
Our Story
Our Story - DYNALABS
Announcements
Announcements - DYNALABS
Announcing a new National Accounts Manager, Christine Versichele.
Announcing a new National Accounts Manager, Christine Versichele. - DYNALABS
DYNALABS announces new Chief Technology Officer
DYNALABS announces new Chief Technology Officer - DYNALABS
DYNALABS welcomes a new Principal Consultant
DYNALABS welcomes a new Principal Consultant - DYNALABS
DYNALABS embarks on $1.2 million expansion
DYNALABS embarks on $1.2 million expansion - DYNALABS
DYNALABS Announces a New Vice President of Sales
DYNALABS Announces a New Vice President of Sales - DYNALABS
DYNALABS announces Director of Quality & Regulatory Affairs
DYNALABS announces Director of Quality & Regulatory Affairs - DYNALABS
DYNALABS Enhances Antimicrobial Effectiveness Testing for USP
DYNALABS Enhances Antimicrobial Effectiveness Testing for USP - DYNALABS
Potency Testing for Oxytocin
Potency Testing for Oxytocin - DYNALABS
DYNALABS Announces New President
DYNALABS Announces New President - DYNALABS
DYNALABS investment doubles the size of its testing facility
DYNALABS investment doubles the size of its testing facility - DYNALABS
Custom Packing Slip
Custom Packing Slip - DYNALABS
DYNALABS Receives ISO/IEC 17025 Accreditation
DYNALABS Receives ISO/IEC 17025 Accreditation - DYNALABS
DYNALABS investment doubles the size of its testing facility
DYNALABS investment doubles the size of its testing facility - DYNALABS
Enforcing FDA Labeling Policies
Enforcing FDA Labeling Policies - DYNALABS
Entrepreneurial Success Award
Entrepreneurial Success Award - DYNALABS
Events
Events - DYNALABS
Vision, Mission
Vision, Mission - DYNALABS
Leadership
Leadership - DYNALABS
Partners and Alliances
Partners and Alliances - DYNALABS
Investor Information
Investor Information - DYNALABS
Resources
Resources - DYNALABS
Webinars
Webinars - DYNALABS
Blogs
Blogs - DYNALABS
Industry News
Industry News - DYNALABS
FDA to Remove APIs from list
FDA to Remove APIs from list - DYNALABS
FDA Drug Shortages
FDA Drug Shortages - DYNALABS
The Pharma Reports
The Pharma Reports - DYNALABS
Careers
Careers - DYNALABS
Contact
Contact - DYNALABS
Client Case StudyWorking Towards 503B Certification
Working Towards 503B Certification - DYNALABS
Client Case StudyDVx™ for On-site Drug Verification
DVx™ for On-site Drug Verification - DYNALABS
Client Case StudyPartnering for 503B Compliance
Partnering for 503B Compliance - DYNALABS
Terms Of Use
Terms Of Use - DYNALABS
Privacy Policy
Privacy Policy - DYNALABS
Customer Agreement
Customer Agreement - DYNALABS

Dynalabs.us Spined HTML

Working Towards 503B Certification - DYNALABS 888.396.2522 314.241.3962 888.396.2522   •   314.241.3962   •   info@dynalabs.us LOGIN User Registration Account Registration  Menu Close Login User Registration Account Registration Products & Services Lab Services State-of-the-art tampering testing laboratory provides data you need to run your business. On Site Testing Less than 4 seconds to objectively verify drug identity and strength in your facility. CQI Program Use our expert knowledge of the pharmaceutical industry to help you grow your business. Continuous Quality Improvement (CQI) Consulting ServicesConsumerImprovement SystemConsumerProduction System Data Analytics Laboratory Services Test Services Lab Services API (Active Pharmaceutical Ingredient ) list DVx™ On site Drug Verification DVx™ Specifications DVx™ Validation Process DVx™ General FAQs On-site Managed Services Consulting Improvement Systems Production System Six Step Approach DYNALABS OOS Process Online Services Sample SubmissionConsumerService What We DoHospital Pharmacies Stability of Drug Diversion of Drug In House Training Product Validation Drug Investigation Compounding Pharmacies People: Training Validation Program Materials: Vendor Qualification Program Equipment: Performance Validation Program Process: Process Validation Program Product: Product Validation Program Frequently Asked Questions CompanyOur Story Announcements Announcing a new National Accounts Manager, Christine Versichele. DYNALABS announces new Chief Technology Officer DYNALABS welcomes a new Principal Consultant DYNALABS embarks on $1.2 million expansion DYNALABS Announces a New Vice President of Sales DYNALABS announces Director of Quality & Regulatory Affairs DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017 DYNALABS named to the 50 Fastest Growing Companies of 2017 DYNALABS Enhances Antimicrobial Effectiveness Testing for USP Potency Testing for Oxytocin DYNALABS Announces New President DYNALABS investment doubles the size of its testing facility Custom Packing Slip DYNALABS Receives ISO/IEC 17025 Accreditation Entrepreneurial Success SmallMerchantryof the Year 2016 DYNALABS investment doubles the size of its testing facility Enforcing FDA Labeling Policies Entrepreneurial Success Award Events Registrations and Awards Vision, Mission Leadership Partners and Alliances Investor Information ResourcesWebinars Blogs Industry News FDA to Remove APIs from list FDA Drug Shortages The Pharma Reports The Pharma Report | Sept 2018 Tech Bulletin | June 2018 Tech Bulletin | May 2018 Tech Bulletin | April 2018 Tech Bulletin | March 2018 Tech Bulletin | February 2018 Tech Bulletin | January 2018 Tech Bulletin | December 2017 Careers Contact < Home | ClientSpecimenStudy | Working Towards 503B Certification Working Towards 503B CertificationSpecimenStudy: Improving Consistency and Building Trust for a 503A Facility Working Towards 503B Certification DYNALABS provides unceasingly high-level service and the weightier turnaround times in the industry. Our quality consumer service is focused on solutions, not just results. So we can provide our clients with opportunities to modernize and grow their business. This specimen study will show how DYNALABS was worldly-wise to use their expert consumer service and pharmaceutical knowledge to build a relationship of trust with a facility that had poor experiences with other testing companies. The Issue In 2013, Federal and State laws mandated that Facility A, a 503A facility, had to wilt a 503b outsourcing facility. To meet that goal, Facility A began looking for a testing visitor or companies to provide the support they needed. Consistency and reliability were expressly important as they worked towards rhadamanthine a 503b outsourcing facility. The testing companies they found at that time were not satisfactory. They all offered variegated levels of service, variegated turnaround times, and inconsistent pricing. Because of these inconsistencies, Facility A began looking for a single, reliable and resulting testing visitor to meet all their testing needs. The Solution Facility A approached some cGMP (Good Manufacturing Practices) consultants for suggestions of a testing visitor to replace their current testing companies. The consultants suggested DYNALABS. So, Facility A approached DYNALABS to determine whether they would provide the consistency, reliability, and reasonable pricing they needed. DYNALABS staff immediately recognized the need to build trust with Facility A, due to their difficulties with other testing companies. So, in wing to DYNALABS standard consumer research and review, a knowledgeable DYNALABS staff member visited Facility A. Then DYNALABS invited Facility A representatives to visit the DYNALABS testing facility and perform their own audit. The Facility A representatives were pleased with the results of their visit and inspect at DYNALABS. The inspect provided Facility A and DYNALABS spare opportunities to have unshut and unslanted discussions well-nigh Facility A’s needs. DYNALABS gave Facility A what they needed to build trust in DYNALABS without their previous negative experiences with other testing companies. The Result Facility A began using DYNALABS in 2013. They have achieved their 503b certification and protract to use DYNALABS exclusively as their testing company. Share This:FacebookTwitterLinkedin Leave a Reply Cancel reply Your email write will not be published. Required fields are marked *Comment Name * Email * Website Currently you have JavaScript disabled. In order to post comments, please make sure JavaScript and Cookies are enabled, and reload the page. Click here for instructions on how to enable JavaScript in your browser. DYNALABS LLC is registered with the U.S. Food and Drug Administration (FDA), DEA and Bureau of Narcotics and Dangerous Drugs licensed, as well as ISO 17025 accredited. The products and services provided by DYNALABS are protected by U.S. Patent Nos. 7,197,405 and 7,660,678. © 2018 DYNALABS LLC. All Rights Reserved. For spare information well-nigh DYNALABS please undeniability 888-396-2522   •   info@dynalabs.usTerms Of Use   •   Privacy Policy   •  ConsumerAgreement